[1] European Food Safety Authority 2014, Scientific Opinion on Dietary Reference Values for folate, Accessed 10
th March 2017,
https://www.efsa.europa.eu/sites/default/files/consultation/140722.pdf
[2] Nutrient Reference Values for Australian and New Zealand, 2014, Folate, Accessed 10th March 2017, https://www.nrv.gov.au/nutrients/folate
[3] Scholl, T & Johnson, W 2002, ‘Folic acid: influence on the outcome of pregnancy’, The American Journal of Clinical Nutrition, vol. 71, no. 5, pp. 1295s-1303s.
[4] Gropper, S, Smith, J & Groff, J 2004, ‘Advanced Nutrition and Human Metabolism’, 4th Edition, Wadsworth, USA.
[5] Kelly, G 1998, ‘Folates: Supplemental Forms and Therapeutic Applications’, Alternative Medicine Review, vol. 3, No. 3, pp. 208-20.
[6] Thorne Research 2005, Folic Acid, Alternative Medicine Review, vol. 10, no. 3, pp. 222-9.
[7] Kelly, P, McPartlin, J, Goggins, M, Weir, DG & Scott, JM 1996, ‘Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements’, American Journal of Clinical Nutrition, vol. 65, no. 6, pp. 1790–5.
[8] Smith, D, Young-In Kim & Refsum, H 2008, ‘Is folic acid good for everyone?’, American Society for Nutrition, vol. 87, no. 3, pp. 517-33.
[9] Whitehead, VM, Pratt, R, Viallet, A, Cooper, BA 1972, ‘Intestinal conversion of folinic acid to 5- methyltetrahydrofolate in man’, British Journal of Haematology, vol. 22, no. 1, pp. 63-72.
[10] Levitt, M, Nixon, PF, Pincus, JH & Bertino, JR 1971, ‘Transport characteristics of folates in cerebrospinal fluid; a study utilizing doubly labeled 5-methyltetrahydrofolate and 5-formyltetrahydrofolate’, Journal of Clinical Investigation, vol. 50, pp. 1301-8.
[11] Spector, R ‘Cerebrospinal fluid folate and the blood-brain barrier’, In: Botez, MI & Reynolds, EH 1979, Folic Acid in Neurology, Psychiatry, and Internal Medicine, New York: Raven Press
[12] Willems FF, Boers GH, Blom HJ, Aengevaeren WR, Verheugt FW, 2004, ‘Pharmacokinetic study on the utilisation of 5-methyltetrahydrofolate and folic acid in patients with coronary artery disease’ British Journal of Pharmacology, vol. 141, no. 5, pp. 825-30.
[13] Oberg, E, Givant, C, Fisk, B, Parikh, C & Bradley, R 2015, Epigenetics in Clinical Practice: Characterizing Patient and Provider Experiences with MTHFR Polymorphisms and Methylfolate, J Nutrigenet Nutrigenomics, vol. 8, pp. 137–150.